The placebo effect in pharmacological treatment of obstructive sleep apnea, a systematic review and meta-analysis.

[1]  B. Corser,et al.  Effects of atomoxetine plus a hypnotic on obstructive sleep apnea severity in patients with a moderately collapsible pharyngeal airway. , 2023, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

[2]  J. Hedner,et al.  Turning Over a New Leaf-Pharmacologic Therapy in Obstructive Sleep Apnea. , 2022, Sleep medicine clinics.

[3]  J. Hedner,et al.  A Randomized Controlled Trial Exploring Safety and Tolerability of Sulthiame in Sleep Apnea. , 2022, American journal of respiratory and critical care medicine.

[4]  G. Parati,et al.  Reboxetine plus Oxybutynin for Obstructed Sleep Apnea Treatment A 1-week Randomized, Placebo-controlled, Double-Blind Crossover Trial. , 2021, Chest.

[5]  C. Juhl,et al.  Placebo response and effect in randomized clinical trials: meta-research with focus on contextual effects , 2021, Trials.

[6]  T. Gaisl,et al.  Night-to-night variability of respiratory events in obstructive sleep apnoea: a systematic review and meta-analysis , 2020, Thorax.

[7]  T. Gaisl,et al.  Low Repeatability of Epworth Sleepiness Scale After Short Intervals in a Sleep Clinic Population. , 2020, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

[8]  Luigi Taranto-Montemurro,et al.  Targeting Endotypic Traits with Medications for the Pharmacological Treatment of Obstructive Sleep Apnea. A Review of the Current Literature , 2019, Journal of clinical medicine.

[9]  Vorakamol Phoophiboon,et al.  A randomized, double-blind, placebo-controlled trial on the effect of intranasal corticosteroid as a treatment for moderate to severe obstructive sleep apnea with coexisting chronic rhinitis , 2019, Sleep and control of breathing.

[10]  S. Redline,et al.  More than the Sum of the Respiratory Events: Personalized Medicine Approaches for Obstructive Sleep Apnea. , 2019, American journal of respiratory and critical care medicine.

[11]  Natalie S Blencowe,et al.  RoB 2: a revised tool for assessing risk of bias in randomised trials , 2019, BMJ.

[12]  S. Haile,et al.  Efficacy of pharmacotherapy for OSA in adults: A systematic review and network meta-analysis. , 2019, Sleep medicine reviews.

[13]  Kevin J. Gleason,et al.  The role of sham continuous positive airway pressure as a placebo in controlled trials: Best Apnea Interventions for Research Trial. , 2019, Sleep.

[14]  L. Colloca.  The Placebo Effect in Pain Therapies. , 2019, Annual review of pharmacology and toxicology.

[15]  Charlene P. Spiceland,et al.  Effects of Medical Therapy on Mild Obstructive Sleep Apnea in Adult Patients. , 2017, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

[16]  J. Stradling,et al.  Minimum important difference of the Epworth Sleepiness Scale in obstructive sleep apnoea: estimation from three randomised controlled trials , 2018, Thorax.

[17]  R. Chervin,et al.  A randomized, subject and rater-blinded, placebo-controlled trial of dimethyl fumarate for obstructive sleep apnea , 2018, Sleep.

[18]  D. McKenzie,et al.  Effect of 1 month of zopiclone on obstructive sleep apnoea severity and symptoms: a randomised controlled trial , 2018, European Respiratory Journal.

[19]  Malcolm Kohler,et al.  Challenges and perspectives in obstructive sleep apnoea , 2018, European Respiratory Journal.

[20]  A. Campbell,et al.  Clinical Reproducibility of the Epworth Sleepiness Scale for Patients With Suspected Sleep Apnea. , 2018, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

[21]  T. Kaptchuk,et al.  Learned immunosuppressive placebo responses in renal transplant patients , 2018, Proceedings of the National Academy of Sciences.

[22]  F. Fuchs,et al.  Diuretic or sodium-restricted diet for obstructive sleep apnea—a randomized trial , 2018, Sleep.

[23]  A. Simonds,et al.  The Epworth Sleepiness Scale: Minimum Clinically Important Difference in Obstructive Sleep Apnea. , 2017, American journal of respiratory and critical care medicine.

[24]  N. Glozier,et al.  A systematic review and meta-analysis of placebo versus no treatment for insomnia symptoms. , 2017, Sleep medicine reviews.

[25]  K. Reid,et al.  Pharmacotherapy of Apnea by Cannabimimetic Enhancement, the PACE Clinical Trial: Effects of Dronabinol in Obstructive Sleep Apnea , 2018, Sleep.

[26]  G. Duarte,et al.  Placebo and nocebo responses in restless legs syndrome , 2017, Neurology.

[27]  Niran Hunchaisri,et al.  Efficacy of Donepezil in the Treatment of Obstructive Sleep Apnea: A Placebo-Controlled Trial. , 2016, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[28]  P. Tsao,et al.  Does enhanced insulin sensitivity improve sleep measures in patients with obstructive sleep apnea: a randomized, placebo-controlled pilot study. , 2016, Sleep medicine.

[29]  S. Crowe,et al.  The Cognitive Effects of Obstructive Sleep Apnea: An Updated Meta-analysis. , 2016, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[30]  M. Preisig,et al.  Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study. , 2015, The Lancet. Respiratory medicine.

[31]  K. Franklin,et al.  Effects of Radiofrequency versus sham surgery of the soft palate on daytime sleepiness , 2014, The Laryngoscope.

[32]  Jiming Liu,et al.  Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range , 2014, BMC Medical Research Methodology.

[33]  J. Hedner,et al.  Zonisamide reduces obstructive sleep apnoea: a randomised placebo-controlled study , 2014, European Respiratory Journal.

[34]  R. Bissonnette,et al.  Effect of adalimumab on sleep parameters in patients with psoriasis and obstructive sleep apnea: a randomized controlled trial , 2014, The Journal of dermatological treatment.

[35]  C. Cingi,et al.  The Effects of Mometasone Furoate and Desloratadine in Obstructive Sleep Apnea Syndrome Patients with Allergic Rhinitis , 2013, American journal of rhinology & allergy.

[36]  S. Zakynthinos,et al.  The effect of nasal tramazoline with dexamethasone in obstructive sleep apnoea patients , 2013, European Respiratory Journal.

[37]  R. Velluti,et al.  Achyrocline satureioides (LAM) D.C. would improve sleep quality in patients with Obstructive Sleep Apnea Syndrome: a pilot study , 2013 .

[38]  J. Ioannidis,et al.  Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials , 2011, BMJ : British Medical Journal.

[39]  A. Malhotra,et al.  Eszopiclone increases the respiratory arousal threshold and lowers the apnoea/hypopnoea index in obstructive sleep apnoea patients with a low arousal threshold. , 2011, Clinical science.

[40]  J. Herdegen,et al.  Prospective trial of efficacy and safety of ondansetron and fluoxetine in patients with obstructive sleep apnea syndrome. , 2010, Sleep.

[41]  B. Gaymard,et al.  Proof of concept study: does fenofibrate have a role in sleep apnoea syndrome? , 2010, Current medical research and opinion.

[42]  David A. Schulman,et al.  Evaluation of sham-CPAP as a placebo in CPAP intervention studies. , 2010, Sleep.

[43]  S. Hofmann,et al.  Meta-analysis of the placebo response in antidepressant trials. , 2009, Journal of affective disorders.

[44]  Anup V. Desai,et al.  Two randomized placebo-controlled trials to evaluate the efficacy and tolerability of mirtazapine for the treatment of obstructive sleep apnea. , 2008, Sleep.

[45]  C. Guilleminault,et al.  Donepezil improves obstructive sleep apnea in Alzheimer disease: a double-blind, placebo-controlled study. , 2008, Chest.

[46]  W. T. McNicholas,et al.  Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities , 2006, European Respiratory Journal.

[47]  H. Basun,et al.  A randomized placebo‐controlled trial of an NMDA receptor antagonist in sleep‐disordered breathing , 2005, Journal of sleep research.

[48]  E. Bixler,et al.  Marked decrease in sleepiness in patients with sleep apnea by etanercept, a tumor necrosis factor-alpha antagonist. , 2004, The Journal of clinical endocrinology and metabolism.

[49]  W. McNicholas,et al.  Intranasal corticosteroid therapy for obstructive sleep apnoea in patients with co-existing rhinitis. , 2004, Thorax.

[50]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[51]  T. Young,et al.  Epidemiology of obstructive sleep apnea: a population health perspective. , 2002, American journal of respiratory and critical care medicine.

[52]  L. Knaack,et al.  Association between blood pressure reduction with antihypertensive treatment and sleep apnea activity. , 2000, American journal of hypertension.

[53]  H. Magnussen,et al.  The therapeutic effect of theophylline in mild obstructive sleep Apnea/Hypopnea syndrome: results of repeated measurements with portable recording devices at home. , 2000, European journal of medical research.

[54]  D. Navajas,et al.  Sham continuous positive airway pressure for placebo-controlled studies in sleep apnoea , 1999, The Lancet.

[55]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[56]  D. Köhler,et al.  Benzodiazepine receptor antagonist (flumazenil) does not affect sleep-related breathing disorders. , 1996, The European respiratory journal.

[57]  R. Duclaux,et al.  Naltrexone improves blood gas patterns in obstructive sleep apnoea syndrome through its influence on sleep , 1993, Journal of sleep research.

[58]  J. Peter,et al.  Senkt Plazebo den nächtlichen Blutdruck bei schlaf bezogenen Atmungsstörungen und arterïeller Hypertonie , 1993 .

[59]  E. R. Mcfadden,et al.  Influences of Suggestion on Airway Reactivity in Asthmatic Subjects , 1968, Psychosomatic medicine.